After August 17, 2026, Novus Biologicals products and services will no longer be available on this website; you will access all products and services on rndsystems.com. Create your R&D Systems online account today.
202-IL) stimulates proliferation in the MO7e human megakaryocytic leukemic cell line in a dose-dependent manner (orange line). Proliferation elicited by Recombinant Human IL-2 (30 ng/mL) is neutralized (green line) by increasing concentrations of Goat Anti-Human Common gamma Chain/ IL-2 R gamma Antigen Affinity-purified Polyclonal Antibody (Catalog # AF284). The ND50 is typically 20-60 µg/mL." class="big_lightbox" target="_blank">
MAB0041, open histogram), followed by Allophycocyanin-conjugated Anti-Mouse IgG F(ab')2Secondary Antibody (Catalog # F0101B)." class="big_lightbox" target="_blank">
202-IL) stimulates proliferation in the MO7e human megakaryocytic leukemic cell line in a dose-dependent manner (orange line). Proliferation elicited by Recom-binant Human IL-2 (200 ng/mL) is neutralized (green line) by increasing concentrations of Mouse Anti-Human Common gamma Chain/IL-2 R gamma Monoclonal Antibody (Catalog # MAB2842). The ND50 is typically 0.08-0.4 µg/mL." class="big_lightbox" target="_blank">
202-IL) stimulates proliferation in the MO7e human megakaryocytic leukemic cell line in a dose-dependent manner (orange line), as measured by Resazurin (Catalog # AR002). Proliferation elicited by Recombinant Human IL-2 (30 ng/mL) is neutralized (green line) by increasing concen-trations of Mouse Anti-Human Common gamma Chain/IL-2 R gamma Monoclonal Antibody (Catalog # MAB284). The ND50 is typically 2.5-15 µg/mL." class="big_lightbox" target="_blank">
223-2A), Recombinant Human IL-2R beta Protein (224-2B) and Recombinant Human IL-2 Protein (202-IL) with an ED50 of 0.100-1.00 μg/mL." class="big_lightbox" target="_blank">
The interleukin 2 (IL2) receptor gamma chain (IL2RG), an important signalling component of many interleukin receptors(IL2,IL4,IL7,IL9, and IL15), is thus referred to as the common gamma chain. Mutations in this X-chromosome-linked genecause X-linked severe combined immunodeficiency (XSCID). (provided by RefSeq)